<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <atom:link rel="self" type="application/rss+xml" href="https://www.mynewsdesk.com/dk/rss/source/40/document"/>
    <title>AstraZeneca A/S - dokumenter</title>
    <link>https://www.mynewsdesk.com/dk/astrazeneca/documents</link>
    <description>Mynewsdesk nyhedsfeed direkte fra kilden</description>
    <image>
      <title>AstraZeneca A/S - dokumenter</title>
      <link>https://www.mynewsdesk.com/dk/astrazeneca/documents</link>
      <url>https://www.mynewsdesk.com/assets/graphics/logos/logo-small-3b24ab90.png</url>
      <width>128</width>
      <height>23</height>
    </image>
    <language>sv</language>
    <ttl>15</ttl>
<item>
  <title>HER2-positiv brystkraeft</title>
  <pubDate>Mon, 20 Sep 2021 14:04:02 +0200</pubDate>
  <description></description>
  <guid>https://www.mynewsdesk.com/dk/astrazeneca/documents/her2-positiv-brystkraeft-414822?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=document</guid>
  <link>https://www.mynewsdesk.com/dk/astrazeneca/documents/her2-positiv-brystkraeft-414822?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=document</link>
  <dc:creator>AstraZeneca AB</dc:creator>
</item>
<item>
  <title>Generelt om brystkraeft</title>
  <pubDate>Mon, 20 Sep 2021 14:01:53 +0200</pubDate>
  <description>Generelt om brystkraeft</description>
  <guid>https://www.mynewsdesk.com/dk/astrazeneca/documents/generelt-om-brystkraeft-414821?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=document</guid>
  <link>https://www.mynewsdesk.com/dk/astrazeneca/documents/generelt-om-brystkraeft-414821?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=Subscription&amp;utm_content=document</link>
  <dc:creator>AstraZeneca AB</dc:creator>
</item>
  </channel>
</rss>
